Paul Hastings LLP advised Fontainebleau Development on the transaction. Fontainebleau closed negotiations and documentation related to: An operating lease for the entire property with the joint venture...
Fontainebleau Development’s Agreements With Fontainebleau Las Vegas Hotel and Casino
Red Sea Global and Amaala Company’s Agreements with Four Seasons for Two Luxury Resorts and Private Residences Projects
Paul Hastings LLP advised Red Sea Global and Amaala Company in the deal. Red Sea Global and Amaala Company closed the negotiation of all hotel and residential...
Starwood Impact Investors’ Investment in Obsidian Capital Partners
Paul Hastings LLP advised Starwood Impact Investors in the transaction. Starwood Impact Investors announced its investment in Obsidian Capital Partners. Through the partnership, Starwood will invest capital...
Francisco Partners’ $1.2 Billion Acquisition of Jama Software
Paul Hastings advised Francisco Partners, while Willkie advised Jama Software and its controlling shareholder, Insight Partners, on the transaction. Jama Software, a requirements management and traceability...
Amaala Company’s Development of Ultra Luxury Wellness and Longevity Health Resort with World Renowned Clinique La Prairie
Paul Hastings LLP advised Amaala Company in the transaction. Amaala Company closed the negotiation of hotel and residential agreements with world renowned spa-clinic leader Clinique La...
TPG’s Investment in Syre
Paul Hastings (Europe) LLP acted as ESG Counsel for TPG on the deal. TPG, a leading global alternative asset manager with $222bn in assets under management,...
Evolus’ $50.0 Million Common Stock Offering
Paul Hastings LLP advised Leerink Partners and Stifel as joint bookrunning managers in the offering. Evolus, Inc. (Nasdaq: EOLS) announced the pricing of its underwritten offering...
Skye Bioscence’s $40 Million Private Placement Equity Financing
Paul Hastings LLP advised Piper Sandler and Co. as lead placement agent, and Oppenheimer & Co. as placement agent in the transaction. Skye Bioscience, Inc. (OTCQB:...
Lexeo Therapeutics’ $95 Million Private Placement
Paul Hastings LLP advised J.P. Morgan and Leerink Partners as co-lead placement agents, and Stifel co-placement agent, in the transaction. Lexeo Therapeutics, Inc. (Nasdaq: LXEO) has entered...
VFLA EventCo LLC v. William Morris Endeavor Entertainment, LLC et al.
Paul Hastings secured an outright victory in the California Court of Appeal on behalf of William Morris Endeavor Entertainment, LLC (“WME”), when the panel affirmed the...
Viking Therapeutics’ $632.5 Million Common Stock Offering
Paul Hastings advised Viking Therapeutics on the offering. Viking Therapeutics, Inc. (Nasdaq: VKTX) executed its underwritten offering of $632.5 million of shares of its common stock....
Salt Mobile’s €150 Million Term Loan Facility
Paul Hastings LLP advised Goldman Sachs International and BNP as lenders in the transaction. Matterhorn Telecom S.A., the parent company of Salt Mobile S.A., announced the...